Konecny, G <br/><br/>
Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Aug 2001 
 - 2448-57 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Breast Neoplasms--genetics<br/>Disease-Free Survival<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genetic Vectors--genetics<br/>Humans<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Metastasis<br/>Ovarian Neoplasms--genetics<br/>Plasminogen Activator Inhibitor 1--analysis<br/>Receptor, ErbB-2--analysis<br/>Retroviridae--genetics<br/>Trastuzumab<br/>Tumor Cells, Cultured<br/>Urokinase-Type Plasminogen Activator--analysis